BAX: Baxter International Inc. Company Assets

Corporate emblem and logo of Baxter International Inc. (BAX)

Baxter International (BAX) produces life-support systems and dialysis equipment, demonstrating immunity to economic shocks. This price trend on GURU.Markets captures total assets at 20886.08. However, product defect lawsuits and limited government budgets are constraining growth rates. The company is currently optimizing its asset structure, divesting unprofitable segments to increase profitability.

Baxter (BAX) Company Total Assets: for the period 07/04/2022 - 10/28/2026

Financial and market metric breakdowns for Baxter Corp (BAX)

- price and consensus price forecast:
Stock Quotes baxter.com|BAX - Analyst Consensus Forecast
- market capitalization data:
Market Value Baxter Healthcare|BAX - Enterprise Value
- book capitalization data:
Equity per Share Baxter|BAX - Book Capitalization|Market Capitalization to Book Value baxter.com|BAX - Company Total Assets
- debt and liquidity data:
Total Debt to Equity Ratio Baxter International|BAX - Long-Term Debt to Capital|Short-Term Debt to Capital Baxter Healthcare|BAX - Company Debts|Debt to Book Capitalization Ratio Baxter Healthcare|BAX - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Baxter
Basic company analysis:BAX, baxter.com
Manufactured product of Baxter Corp

Baxter International maintains its status as a critical medical equipment supplier, with reliability validated by the trust of hospitals worldwide. The trend in total assets, calculated reverse-engineered via ROA, digitizes the efficiency with which the company utilizes all its resources to generate profit. Current fluctuations in total assets reflect the results of restructuring and the upgrading of the material base. It is essential for investors to benchmark this volume against industry peers to distinguish systemic growth from inert balance sheet inflation.

Competitors of Baxter International (BAX)

intuitive.com (ISRG) - Cumulative Company Assets|Company Total Assets DHR (Danaher)|Company Assets BD|Company Total Assets STERIS Corporation STE|Total Business Assets West Pharma Corp (WST)|Company Total Assets MASI|Company Total Asset Base stevanatogroup.com STVN|TFX: Company Total Assets|MMSI - Cumulative Company Assets|NVST: Company Total Assets|ICUI (ICU Medical Inc.) - Company Total Assets|Aggregate Company Assets DENTSPLY SIRONA Inc.|Aggregate Company Assets lemaitre.com (LMAT)|AtriCure (ATRC) - Cumulative Company Assets|Aggregate Asset Value STAAR Surgical Co. (STAA)|Company Total Assets NAGE|ZimVie Corp - Company Total Asset Base|AngioDynamics, Inc. (ANGO) - Aggregate Company Assets|CERS: Total Business Assets|Teknova - Aggregate Company Assets|Company Total Asset Base Monogram Technologies Inc.|Sharps Technology Inc (STSS) - Cumulative Company Assets|Aggregate Business Assets INFU|Utah Medical Products (UTMD) - Aggregate Company Assets|Aggregate Asset Value korumedical.com KRMD|Cumulative Company Assets NYXH (Nyxoah)|Microbot Medical, Inc. - Company Total Assets|PDEX: Aggregate Company Assets|ZTEK - Cumulative Company Assets|Company Total Assets ELUT|MLSS (milestonescientific.com) - Company Assets|Aggregate Company Assets NEXGEL (NXGL)|Total Business Assets Retractable Tech (RVP)|Cumulative Company Assets Harvard Bioscience|Aggregate Business Assets FEMY (Femasys Corporation)|Aggregate Company Assets MHUA|Company Total Asset Base Predictive Oncology Inc POAI|CJMB - Company Total Assets|ATRI - Aggregate Company Assets|NURO: Company Total Assets